John Oliver tackles America's opioid and heroin crisis, and boy is he mad at Big Pharma


"I would like to talk to you about drugs," John Oliver said on Sunday's Last Week Tonight, but not in some 1960s "reefer madness" way. "Unfortunately, America is now in the midst of a new drug crisis, and it seems that no one is safe from it," he said. That would be the "epidemic of addiction to opioids, like heroin and prescription painkillers," he said, and it's a serious one: As of 2015, an estimated 2.6 million Americans were addicted to these drugs, and some 30,000 Americans die from overdoses each year from heroin and prescription opioids.
Oliver focused on the prescription variety, the chemical cousins of heroin that some 75 percent of U.S. heroin addicts started their addiction with. Now, according to the U.S. surgeon general, some 250 million opioid prescriptions are written each year, equal to one for each adult. It wasn't always this way — as recently as the early 1990s, doctors were "excessively wary" about prescribing these powerful, addictive drugs, Oliver said. And it wasn't just Big Pharma — patient advocates argued that excessive fear of opioids was causing injured and dying people too much pain. But when Perdue — maker of OxyContin — and other drug companies got involved in the late 1990s, he said, all hell broke loose.
After discussing Perdue's shady marketing and downplaying of addiction risk, Oliver said we "may be glad to hear that in 2007 they admitted some responsibility," paying out $634 million. "But at a certain point, the question has to become less 'What did we do wrong?' and more 'What do we do now?'" Oliver said. "There is no one simple answer here." We need to be more careful about prescribing opioids and make alternative treatments more widely available, he said, but "not all opioid addicts will respond to the same treatments, and not all people in pain will find relief from alternative therapies. This is going to take a massive effort and a significant investment — it won't be cheap, it won't be quick, and it won't be easy. And it is hard not to be angry at the drug companies, like Purdue, whose promise of cheap, quick, easy pain solution helped put us in this f---ing mess." Watch below, and be warned, that last F-bomb isn't bleeped out. Peter Weber
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Mermaiding: the underwater subculture on the rise
Under the Radar Cosplay meets fitness in an escapist fin-omenon that's making waves around the world
-
Delhi's dogs earn Supreme Court reprieve
IN THE SPOTLIGHT After an outcry from the public and animal rights activists, India's Supreme Court walks back a controversial plan to round the city's stray dog population into shelters
-
8 hotels with ace tennis courts
The Week Recommends Bring your A game
-
New York court tosses Trump's $500M fraud fine
Speed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in Intel
Speed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to China
Speed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with Disney
Speed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year